Chemotherapy and targeted therapy near the end of life affects aggressiveness of palliative care.

Zhang, Zhe; Chen, Meng-Lei; Liu, Ming-Hui; Cheng, Wen-Wu

Zhang, Zhe; Chen, Meng-Lei; Liu, Ming-Hui; Cheng, Wen-Wu.

Afiliación

Zhang Z; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Chen ML; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Liu MH; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Cheng WW; Department of Integrated Therapy, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. sszyys@163.com.

Ann Palliat Med ; 10(3): 2917-2925, 2021 Mar.

Article en En | MEDLINE | ID: mdl-33549022

Asunto(s)

Neoplasias; Cuidado Terminal; China; Muerte; Humanos; Neoplasias/tratamiento farmacológico; Cuidados Paliativos; Estudios Retrospectivos

Palabras clave

Cancer; end of life (EOL); palliative chemotherapy (PCT); targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Cuidado Terminal / Neoplasias Tipo de estudio: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Ann Palliat Med Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google